Biotech
Asia China

Lance Han: Refining Therapeutic Progress through Modeling

As the CEO of Cyagen Biosciences, Lance Han is at the forefront of developing advanced AI models in cell and gene therapy R&D solutions. With a decade of knowledge in creating genetically modified cell and rodent models for research institutions, university laboratories, biotech companies, and clinical researchers, he has gained valuable insights into the scientific […]

Read More
error: Warning: Unauthorized copying detected. Content protected.